A First-Class Degrader Candidate Targeting Both KRAS G12D and G12V Mediated by CANDDY Technology Independent of Ubiquitination
Etsuko Miyamoto‐Sato(Tokyo University of Science), Masamichi Ishizaka
Cited by 11
Related Papers
<i>In vivo</i> KRAS G12D/V degradation mediated by CANDDY using a modified proteasome inhibitor
|bioRxiv (Cold Spring Harbor Laboratory)|2021|4